ID   GM10834
AC   CVCL_5B86
AS   CVCL_G544
SY   GM10834A; CEPH-1416-NA10834; 1416-1188
DR   CLO; CLO_0023796
DR   BioSample; SAMN00800232
DR   Coriell; GM10834
DR   dbMHC; 48703
DR   GEO; GSM25434
DR   GEO; GSM25435
DR   GEO; GSM420600
DR   GEO; GSM420601
DR   GEO; GSM316444
DR   GEO; GSM316445
DR   GEO; GSM316446
DR   GEO; GSM905832
DR   GEO; GSM905927
DR   GEO; GSM906022
DR   IHW; IHW01175
DR   IPD-IMGT/HLA; 13832
DR   Wikidata; Q54844667
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=20856902;
RX   PubMed=30844424;
WW   https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141602.
CC   HLA typing: A*02:01,02:05; B*15:01,49:01; C*03:03,07:01; DPA1*01:03,02:01:01; DPB1*04:01:01,13:01; DQA1*01:02,03:01; DQB1*03:02:01,06:09; DRB1*04:01,13:02; DRB3*01; DRB4*01 (IPD-IMGT/HLA=13832).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 18
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In misc. document) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda; USA (1992).
//
RX   PubMed=14583597; DOI=10.1152/physiolgenomics.00163.2003;
RA   Pastinen T., Sladek R., Gurd S., Sammak A., Ge B., Lepage P.,
RA   Lavergne K., Villeneuve A., Gaudin T., Brandstrom H., Beck A.,
RA   Verner A., Kingsley J., Harmsen E., Labuda D., Morgan K., Vohl M.-C.,
RA   Naumova A.K., Sinnett D., Hudson T.J.;
RT   "A survey of genetic and epigenetic variation affecting human gene
RT   expression.";
RL   Physiol. Genomics 16:184-193(2004).
//
RX   PubMed=20856902; DOI=10.1371/journal.pbio.1000480; PMCID=PMC2939022;
RA   Cheung V.G., Nayak R.R., Wang I.X.-R., Elwyn S., Cousins S.M., Morley M.,
RA   Spielman R.S.;
RT   "Polymorphic cis- and trans-regulation of human gene expression.";
RL   PLoS Biol. 8:e1000480.1-e1000480.14(2010).
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//